Citizens Financial Group Inc. RI Acquires 1,549 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Citizens Financial Group Inc. RI lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,669 shares of the medical equipment provider's stock after buying an additional 1,549 shares during the quarter. Citizens Financial Group Inc. RI's holdings in Intuitive Surgical were worth $5,047,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Sage Mountain Advisors LLC increased its position in Intuitive Surgical by 1.4% in the fourth quarter. Sage Mountain Advisors LLC now owns 1,869 shares of the medical equipment provider's stock worth $976,000 after purchasing an additional 25 shares during the period. Clare Market Investments LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $2,528,000. Independent Advisor Alliance raised its stake in shares of Intuitive Surgical by 22.9% during the fourth quarter. Independent Advisor Alliance now owns 11,946 shares of the medical equipment provider's stock worth $6,235,000 after buying an additional 2,226 shares during the last quarter. Paragon Private Wealth Management LLC lifted its holdings in Intuitive Surgical by 23.9% in the fourth quarter. Paragon Private Wealth Management LLC now owns 1,114 shares of the medical equipment provider's stock valued at $581,000 after buying an additional 215 shares during the period. Finally, Meriwether Wealth & Planning LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $537,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 489 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now directly owns 2,091 shares in the company, valued at $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,309 shares of company stock worth $7,611,004. Corporate insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Barclays upped their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Piper Sandler reaffirmed an "overweight" rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $613.10.

Remove Ads

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $493.72 on Wednesday. The firm has a market cap of $175.85 billion, a price-to-earnings ratio of 77.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock's 50-day moving average is $569.91 and its 200-day moving average is $531.84.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.